Geneviève Gourdon

5.0k total citations
79 papers, 2.8k citations indexed

About

Geneviève Gourdon is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Geneviève Gourdon has authored 79 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 66 papers in Cellular and Molecular Neuroscience and 9 papers in Neurology. Recurrent topics in Geneviève Gourdon's work include Genetic Neurodegenerative Diseases (65 papers), Mitochondrial Function and Pathology (35 papers) and Muscle Physiology and Disorders (24 papers). Geneviève Gourdon is often cited by papers focused on Genetic Neurodegenerative Diseases (65 papers), Mitochondrial Function and Pathology (35 papers) and Muscle Physiology and Disorders (24 papers). Geneviève Gourdon collaborates with scholars based in France, United States and Canada. Geneviève Gourdon's co-authors include Mário Gomes‐Pereira, Claudine Junien, Denis Furling, Stéphanie Tomé, Charles A. Thornton, W. G. Wood, Douglas R. Higgs, Annie Nicole, Aline Huguet and Andrew P. Jarman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Geneviève Gourdon

76 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geneviève Gourdon France 30 2.5k 1.7k 340 310 236 79 2.8k
Sita Reddy United States 27 2.4k 1.0× 1.5k 0.9× 242 0.7× 179 0.6× 113 0.5× 49 2.7k
Xiao–Ning Chen United States 22 1.7k 0.7× 920 0.5× 361 1.1× 396 1.3× 181 0.8× 32 2.3k
Melinda L. Moseley United States 13 2.4k 1.0× 2.1k 1.2× 640 1.9× 305 1.0× 183 0.8× 17 2.7k
Monica Narang Canada 11 1.7k 0.7× 1.3k 0.7× 402 1.2× 291 0.9× 74 0.3× 12 1.9k
Philippe Horellou France 24 1.3k 0.5× 1.0k 0.6× 372 1.1× 697 2.2× 96 0.4× 52 2.3k
Марек Напиерала United States 24 1.6k 0.7× 1.1k 0.6× 129 0.4× 296 1.0× 72 0.3× 57 1.8k
Takeshi Mizuguchi Japan 28 1.6k 0.7× 381 0.2× 151 0.4× 1.2k 3.7× 94 0.4× 126 2.7k
Thurman M. Wheeler United States 17 2.0k 0.8× 1.3k 0.8× 282 0.8× 160 0.5× 267 1.1× 19 2.2k
Nobutada Tachi Japan 16 789 0.3× 619 0.4× 234 0.7× 150 0.5× 58 0.2× 86 1.3k
Puneet Opal United States 25 1.3k 0.5× 852 0.5× 426 1.3× 221 0.7× 90 0.4× 51 2.1k

Countries citing papers authored by Geneviève Gourdon

Since Specialization
Citations

This map shows the geographic impact of Geneviève Gourdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geneviève Gourdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geneviève Gourdon more than expected).

Fields of papers citing papers by Geneviève Gourdon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geneviève Gourdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geneviève Gourdon. The network helps show where Geneviève Gourdon may publish in the future.

Co-authorship network of co-authors of Geneviève Gourdon

This figure shows the co-authorship network connecting the top 25 collaborators of Geneviève Gourdon. A scholar is included among the top collaborators of Geneviève Gourdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geneviève Gourdon. Geneviève Gourdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benarroch, Louise, Pierre‐Yves Boëlle, Nobuyuki Eura, et al.. (2025). Comparative Analysis of CRISPR/Cas9-targeted Nanopore Sequencing Approaches in Repeat Expansion Disorders. Genomics Proteomics & Bioinformatics.
2.
Golini, Elisabetta, Christine Voellenkle, Claudia Provenzano, et al.. (2025). Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1. Clinical and Translational Medicine. 15(2). e70227–e70227. 2 indexed citations
3.
El‐Sherif, Nabil, et al.. (2024). Calcium handling abnormalities increase arrhythmia susceptibility in DMSXL myotonic dystrophy type 1 mice. Biomedicine & Pharmacotherapy. 180. 117562–117562. 1 indexed citations
4.
Jauvin, Dominic, Frank Bennett, Frank Rigo, et al.. (2022). Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1. Human Gene Therapy. 33(15-16). 810–820. 16 indexed citations
5.
Tsai, Yu‐Chih, Cheryl Heiner, Tanya Stojkovic, et al.. (2022). Identification of a CCG-Enriched Expanded Allele in Patients with Myotonic Dystrophy Type 1 Using Amplification-Free Long-Read Sequencing. Journal of Molecular Diagnostics. 24(11). 1143–1154. 13 indexed citations
6.
Cardinali, Beatrice, Claudia Provenzano, Christine Voellenkle, et al.. (2021). Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene. Molecular Therapy — Nucleic Acids. 27. 184–199. 13 indexed citations
7.
Nakamori, Masayuki, Yoan Renaud, Aline Huguet, et al.. (2019). Straightjacket/α2δ3 deregulation is associated with cardiac conduction defects in myotonic dystrophy type 1. eLife. 8. 10 indexed citations
8.
Bráz, Sandra, et al.. (2019). Real Time Videomicroscopy and Semiautomated Analysis of Brain Cell Culture Models of Trinucleotide Repeat Expansion Diseases. Methods in molecular biology. 2056. 217–240. 1 indexed citations
9.
Jauvin, Dominic, Sanjay K. Pandey, Guillaume Bassez, et al.. (2017). Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice. Molecular Therapy — Nucleic Acids. 7. 465–474. 63 indexed citations
10.
Agtmaal, Ellen L. van, Marieke Willemse, Sarah A. Cumming, et al.. (2017). CRISPR/Cas9-Induced (CTG⋅CAG) n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing. Molecular Therapy. 25(1). 24–43. 95 indexed citations
11.
Sicot, Géraldine, Laurent Servais, Axelle Leroy, et al.. (2017). Downregulation of the Glial GLT1 Glutamate Transporter and Purkinje Cell Dysfunction in a Mouse Model of Myotonic Dystrophy. Cell Reports. 19(13). 2718–2729. 34 indexed citations
12.
Küntzer, Thierry, et al.. (2013). Respiratory failure in a mouse model of myotonic dystrophy does not correlate with the CTG repeat length. Respiratory Physiology & Neurobiology. 189(1). 22–26. 5 indexed citations
13.
Decostre, V., Alban Vignaud, Béatrice Matot, et al.. (2013). Longitudinal in vivo muscle function analysis of the DMSXL mouse model of myotonic dystrophy type 1. Neuromuscular Disorders. 23(12). 1016–1025. 6 indexed citations
14.
Rau, Frédérique, Fernande Freyermuth, Jean-Philippe Villemin, et al.. (2011). Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nature Structural & Molecular Biology. 18(7). 840–845. 219 indexed citations
15.
Castel, Arturo López, Masayuki Nakamori, Stéphanie Tomé, et al.. (2010). Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues. Human Molecular Genetics. 20(1). 1–15. 115 indexed citations
16.
Mulders, Susan, Walther J. A. A. van den Broek, Thurman M. Wheeler, et al.. (2009). Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proceedings of the National Academy of Sciences. 106(33). 13915–13920. 204 indexed citations
17.
Tomé, Stéphanie, Ian Holt, Winfried Edelmann, et al.. (2009). MSH2 ATPase Domain Mutation Affects CTG•CAG Repeat Instability in Transgenic Mice. PLoS Genetics. 5(5). e1000482–e1000482. 77 indexed citations
18.
Megret, Jérôme, et al.. (2006). A simple and fast method for cell recovery and DNA content analysis from various mouse tissues by flow cytometry. Cytotechnology. 52(2). 107–112. 3 indexed citations
19.
Gourdon, Geneviève, Jacqueline A. Sharpe, Dominic J. Wells, W. G. Wood, & Douglas R. Higgs. (1994). Analysis of a 70 kb segment of DNA containing the human ζ and α-globin genes linked to their regulatory element (HS-40) in transgenic mice. Nucleic Acids Research. 22(20). 4139–4147. 43 indexed citations
20.
Jarman, Andrew P., W. G. Wood, Jacqueline A. Sharpe, et al.. (1991). Characterization of the Major Regulatory Element Upstream of the Human a-Globin Gene Cluster. Molecular and Cellular Biology. 11(9). 4679–4689. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sita Reddy Breakdown of academic impact, for papers by Xiao–Ning Chen Breakdown of academic impact, for papers by Melinda L. Moseley Breakdown of academic impact, for papers by Monica Narang Breakdown of academic impact, for papers by Philippe Horellou Breakdown of academic impact, for papers by Марек Напиерала Breakdown of academic impact, for papers by Takeshi Mizuguchi Breakdown of academic impact, for papers by Thurman M. Wheeler Breakdown of academic impact, for papers by Nobutada Tachi Breakdown of academic impact, for papers by Puneet Opal
Rankless by CCL
2026